<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-title>BMC Cancer</journal-title><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2407-9-122</article-id><article-id pub-id-type="pmid">19389261</article-id><article-id pub-id-type="doi">10.1186/1471-2407-9-122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Dietary intake of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12</sub>, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Ma</surname><given-names>Enbo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ema@ncc.go.jp</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Iwasaki</surname><given-names>Motoki</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>moiwasak@ncc.go.jp</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Junko</surname><given-names>Ishihara</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>j3ishiha@nodai.ac.jp</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Hamada</surname><given-names>Gerson Shigeaki</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>ghamada@uol.com.br</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Nishimoto</surname><given-names>Ines Nobuko</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>innishimoto@gmail.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Carvalho</surname><given-names>Solange Maria Torchia</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>solcarvalho@uol.com.br</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Motola</surname><given-names>Juvenal</given-names><suffix>Jr</suffix></name><xref ref-type="aff" rid="I6">6</xref><email>jmottola@uol.com.br</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Laginha</surname><given-names>F&#x000e1;bio Martins</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>laginhaf@uol.com.br</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Tsugane</surname><given-names>Shoichiro</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>stsugane@ncc.go.jp</email></contrib></contrib-group><aff id="I1"><label>1</label>Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan</aff><aff id="I2"><label>2</label>Department of Nutrition, Junior College of Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan</aff><aff id="I3"><label>3</label>Nikkei Disease Prevention Center, S&#x000e3;o Paulo, Brazil</aff><aff id="I4"><label>4</label>Statisitical Section/Head and Neck Surgery and Otorhinolaryngology Department, Hospital AC Camargo, S&#x000e3;o Paulo, Brazil</aff><aff id="I5"><label>5</label>Departamento de Mastologia, Hospital AC Camargo, S&#x000e3;o Paulo, Brazil</aff><aff id="I6"><label>6</label>Department of Breast Surgery, Hospital P&#x000e9;rola Byington, S&#x000e3;o Paulo, Brazil</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>24</day><month>4</month><year>2009</year></pub-date><volume>9</volume><fpage>122</fpage><lpage>122</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/9/122"/><history><date date-type="received"><day>25</day><month>6</month><year>2008</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Ma et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Ma et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Ma Enbo ema@ncc.go.jp </dc:author><dc:title> Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Cancer 9(1): 122-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2407(2009)9:1&#x0003c;122&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2407</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Several studies have determined that dietary intake of B vitamins may be associated with breast cancer risk as a result of interactions between <italic>5,10-methylenetetrahydrofolate reductase (MTHFR) </italic>and <italic>methionine synthase </italic>(<italic>MTR</italic>) in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in Brazilian women in particular has not yet been investigated.</p></sec><sec sec-type="methods"><title>Methods</title><p>A case-control study was conducted in S&#x000e3;o Paulo, Brazil, with 458 age-matched pairs of Brazilian women. Energy-adjusted intakes of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>were derived from a validated Food Frequency Questionnaire (FFQ). Genotyping was completed for <italic>MTHFR </italic>A1298C and C677T, and <italic>MTR </italic>A2756G polymorphisms. A logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).</p></sec><sec><title>Results</title><p>Neither dietary intake of folate, vitamin B<sub>6</sub>, or vitamin B<sub>12 </sub>nor <italic>MTHFR </italic>polymorphisms were independently associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI: 1.23&#x02013;3.83; <italic>P</italic><sub><italic>trend </italic></sub>= 0.010). The <italic>MTR </italic>2756GG genotype was associated with a higher risk of breast cancer than the 2756AA genotype (OR = 1.99, 95% CI = 1.01&#x02013;3.92; <italic>P</italic><sub><italic>trend </italic></sub>= 0.801), and statistically significant interactions with regard to risk were observed between the <italic>MTHFR </italic>A1298C polymorphism and folate (P = 0.024) or vitamin B<sub>6 </sub>(P = 0.043), and between the <italic>MTHFR </italic>C677T polymorphism and folate (P = 0.043) or vitamin B<sub>12 </sub>(P = 0.022).</p></sec><sec><title>Conclusion</title><p><italic>MTHFR </italic>polymorphisms and dietary intake of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>had no overall association with breast cancer risk. However, increased risk was observed in total women with the <italic>MTR </italic>2756GG genotype and in premenopausal women with high folate intake. These findings, as well as significant interactions between <italic>MTHFR </italic>polymorphisms and B vitamins, warrant further investigation.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Folate and other methyl-related B vitamins are essential nutrients which play important roles in DNA synthesis (genetics), repair, and methylation (epigenetics). These roles in turn indicate a potential association for these vitamins with the development of several types of cancer [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. For example, in one folate metabolism pathway, the enzyme <italic>5,10-methylenetetrahydrofolate reductase (MTHFR) </italic>irreversibly catalyzes the conversion of 5,10-methylenetetrahydrofolate (5,10-methylene THF) to 5-methyltetrahydrofolate (5-methyl THF), the methyl donor in DNA methylation. In another, folate leads to purine synthesis in DNA repair [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Activity of the <italic>MTHFR </italic>gene is attenuated by two common genetic polymorphisms, the <italic>MTHFR </italic>C677T and A1298C polymorphisms [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. <italic>Methionine synthase (MTR)</italic>, which catalyzes the remethylation of homocysteine to methionine, has the common genetic polymorphism <italic>MTR </italic>A2756G [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p><p>Several studies have suggested an inverse association between folate intake and breast cancer risk in all women [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B13">13</xref>], pre- [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>], and postmenopausal women [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. However, recent meta-analysis has shown no clear overall association between folate intake or folate levels in the blood and breast cancer risk [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. A number of studies have examined <italic>MTHFR </italic>and <italic>MTR </italic>polymorphisms [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B25">25</xref>] and found that variant genotypes of <italic>MTHFR </italic>C677T are associated with an increased [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B25">25</xref>] or decreased [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B20">20</xref>] risk of breast cancer, while those of <italic>MTHFR </italic>A1298C are associated with a decreased risk [<xref ref-type="bibr" rid="B24">24</xref>] and those of <italic>MTR </italic>A2756G with a decreased risk [<xref ref-type="bibr" rid="B6">6</xref>]. Several studies have further reported on the interaction between these <italic>MTHFR </italic>genotypes and folate intake in affecting risk [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. In addition to the influence of genotype, DNA methylation and synthesis are also subject to the effects of other vitamins relevant to the one-carbon metabolism pathway, including vitamin B<sub>6 </sub>(pyridoxine) as a cofactor of <italic>MTHFR </italic>and vitamin B<sub>12 </sub>as a cofactor of <italic>MTR </italic>[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Although a role for genotype in modifying the association between dietary intake and disease is biologically plausible [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>], research into the protective effects of increasing dietary intake of these B vitamins against breast cancer risk remains inconclusive [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B27">27</xref>].</p><p>In our similar previous case-control study conducted in a Japanese population, we found no significant association between dietary folate intake, <italic>MTHFR </italic>and <italic>MTR </italic>genotype, and breast cancer risk [<xref ref-type="bibr" rid="B28">28</xref>]. Although the incidence of breast cancer is higher in Brazilian than Japanese women [<xref ref-type="bibr" rid="B29">29</xref>], the association between B vitamin intake in the diet, relevant genotypes, and breast cancer risk in Brazilian populations has not been investigated. Here, we conducted a hospital-based case-control study in S&#x000e3;o Paulo, Brazil, to investigate the role of <italic>MTHFR </italic>and <italic>MTR </italic>polymorphisms in modifying the association of folate and other B vitamin intake with breast cancer risk in Brazilian women.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>Eligible cases were a consecutive series of female patients aged 20&#x02013;74 years with newly diagnosed and histologically confirmed invasive breast cancer. Cases were recruited between 2001 and 2006 at eight hospitals in S&#x000e3;o Paulo which historically treat a relatively large number of Japanese-Brazilian patients. Eligible controls confirmed not to have any cancer were selected from the same hospitals, with one control matched to each case by age (within 5 years) and ethnicity (Caucasian, African, Asian, or mixed) during the study period. Primary reasons for study patients visiting a hospital included health check-up (52%), treatment for gynecological (13%; 64% of which were uterine myoma), urological (8%), and dermatological conditions (6%), clinical examination (8%), and others. Of the eligible cases, 472 patients (389 non-Japanese Brazilian [99%] and 83 Japanese-Brazilian [91%]) gave written informed consent, while among potential controls, 22 patients refused, resulting in a total of 472 matched pairs ultimately enrolled. The study was approved by the Comiss&#x000e3;o Nacional de &#x000c9;tica em Pesquisa (CONEP), Bras&#x000ed;lia, Brazil, and by the Institute Review Board of the National Cancer Center, Tokyo, Japan, in 2000.</p></sec><sec><title>Data Collection and Dietary Assessment</title><p>In-person interviews were conducted by trained interviewers using a structured questionnaire which included questions on demographic characteristics, medical history, family history of cancer, anthropometric factors, smoking habits, physical activities, menstrual and reproductive factors, as well as a self-quantitative FFQ with 118 food terms.</p><p>The FFQ used here, developed specifically for this study to estimate dietary intake among participants, inquired about how often participants consumed individual food items (frequency of consumption), as well as about representative relative sizes compared with standard portions in the preceding year (control patients) or one year before their breast cancer diagnosis (cancer patients). Daily food intake was calculated by multiplying frequency by standard portion size and relative size for each food item in the FFQ. Daily intake of nutrients was calculated using the United States Department of Agriculture (USDA) food composition tables [<xref ref-type="bibr" rid="B30">30</xref>] and the Fifth Revised and Enlarged Edition of the Standard Tables of Food Composition in Japan [<xref ref-type="bibr" rid="B31">31</xref>] for intake regarding Japanese-specific foods. The regression-residual model was used to adjust intake of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>[<xref ref-type="bibr" rid="B32">32</xref>]. Our FFQ included questions on supplement use, but nutrient intake data from supplements were not included in analyses, as no comprehensive data for supplements were available.</p><p>The validity of nutrient intake estimated from the FFQ was evaluated in a subsample of the control group. Fifty-five women completed a 4-day dietary record (DR) in two seasons. Spearman's correlation coefficient between energy-adjusted nutrient intakes estimated from the FFQ and DR was 0.30 for folate, 0.38 for vitamin B<sub>6</sub>, and 0.33 for vitamin B<sub>12</sub>.</p></sec><sec><title>Genotype of Polymorphisms</title><p>Peripheral blood samples were obtained from each subject and stored at -80&#x000b0;C until analysis. Genomic DNA samples were extracted from the blood using QIAGEN FlexiGene<sup>&#x000ae; </sup>DNA kits in accordance with the manufacturer's protocol. Genotyping of the three single-nucleotide polymorphisms (SNPs) in the <italic>MTHFR </italic>and <italic>MTR </italic>genes was performed by a commercial laboratory (Genetic Lab., Inc., Sapporo, Japan) using TaqMan<sup>&#x000ae; </sup>SNP Genotyping Assays developed by Applied Biosystems (Framingham, MA, USA). Cases and matched controls were analyzed in the same well by laboratory personnel blinded to case-control status. To assess quality control, we conducted laboratory genotyping of six SNPs of four genes (<italic>N-acetyltransferase 2 </italic>[<italic>NAT2</italic>], <italic>cytochrome P450c17&#x003b1; </italic>[<italic>CYP17</italic>], <italic>aromatase </italic>[<italic>CYP19</italic>], and <italic>cytochrome P450 2E1 </italic>[<italic>CYP2E1</italic>]) using approximately 25% of samples from the present study, although SNPs used in the present study were not included. The concordance rates between Genetic Lab. and our laboratory varied between 97.5% and 99.2% for the six SNPs.</p></sec><sec><title>Data Analysis</title><p>Study subjects with markedly low or high total energy intake (&#x0003c;500 or &#x02265;4000 kcal) or without DNA samples were excluded from the study, leaving 458 pairs of Brazilian women for analysis (379 non-Japanese Brazilian and 79 Japanese-Brazilian pairs). ORs and 95% CIs for associations between dietary intake, polymorphisms, and risk of breast cancer were calculated by the conditional logistical model, and statistical significance was examined by the Wald chi-square test. Baseline characteristics between cases and controls were compared by the Cochran-Mantel-Haenszel test using matched-pair strata. Deviation from the Hardy-Weinberg equilibrium in genotype frequencies was assessed with the chi-square test.</p><p>In the primary analysis of all subjects, risk factors identified by univariate analysis as independently related to disease risk, including smoking habit, alcohol consumption, number of live births, and a moderate level of physical activity in the preceding 5 years, were adjusted in multivariable analyses. Other potential confounders such as age at menarche, age at first live birth, breast feeding, number of pregnancies, and breast cancer in first-degree relatives were not independently associated with breast cancer risk, nor did they substantially modify the effects when tested in the multivariable model (less than 10% change in strength), and were thus not retained. Nutrient intakes of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>were categorized into tertiles for total study subjects based on the distribution among controls, with the lowest tertiles considered as the reference categories.</p><p>To increase statistical power, respective genotypes of less-frequent polymorphisms were also combined into two groups. Genotypes of <italic>MTHFR </italic>677CC and 1298AA, and <italic>MTR </italic>2756AA were considered as the referent group. With regard to evaluation of the interactive effects of SNPs and dietary intakes on breast cancer risk, the combined effects of SNPs and dietary intakes were assessed by adding the multiplicative interaction product (genotype &#x000d7; dietary intake) to the final model as indicator variables.</p><p>In a secondary analysis, we stratified patients by menopause status, alcohol consumption, and vitamin supplement use using an unconditional logistic model which adjusted for identified risk factors as well as age and ethnicity. Further, trend testing was conducted by treating each categorized variable as a continuous term and entering the variable into the logistic regression models. All <italic>p </italic>values reported were two-sided, and the significance level was set at p &#x0003c; 0.05. All analyses were conducted with SAS 9.02 (SAS Institute Inc., Cary, NC, USA).</p></sec></sec><sec><title>Results</title><p>Characteristics of case and control subjects at baseline are shown in Table <xref ref-type="table" rid="T1">1</xref>. The breast cancer case group tended to include more smokers and have higher energy intake, but lower alcohol consumption, less moderate physical activity, fewer live births, and lower vitamin supplement use than the control group.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Characteristics of breast cancer and control subjects at baseline in Brazilian women</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left" colspan="2">Cases (n = 458)</td><td align="left" colspan="2">Controls (n = 458)</td><td align="left"><italic>P*</italic></td></tr></thead><tbody><tr><td></td><td align="left" colspan="5">Mean &#x000b1; SD<sup>&#x02020;</sup></td></tr><tr><td align="left">Age (matching factor), years</td><td align="left">53.2</td><td align="left">&#x000b1; 10.9</td><td align="left">53.2</td><td align="left">&#x000b1; 10.6</td><td align="left">-</td></tr><tr><td align="left">Body mass index, kg/m<sup>2</sup></td><td align="left">26.2</td><td align="left">&#x000b1; 4.7</td><td align="left">25.8</td><td align="left">&#x000b1; 4.2</td><td align="left"><italic>0.207</italic></td></tr><tr><td align="left">Age at menarche, years</td><td align="left">13.1</td><td align="left">&#x000b1; 1.8</td><td align="left">13.1</td><td align="left">&#x000b1; 1.8</td><td align="left"><italic>0.676</italic></td></tr><tr><td align="left">Age at the first live birth, years</td><td align="left">24.0</td><td align="left">&#x000b1; 5.5</td><td align="left">23.3</td><td align="left">&#x000b1; 5.4</td><td align="left"><italic>0.082</italic></td></tr><tr><td align="left">Age at menopause, years</td><td align="left">47.8</td><td align="left">&#x000b1; 6.0</td><td align="left">47.6</td><td align="left">&#x000b1; 5.6</td><td align="left"><italic>0.689</italic></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td align="left" colspan="5">Number (%)</td></tr><tr><td align="left">Japanese-Brazilian ethnicity</td><td align="left">79</td><td align="left">(20.8)</td><td align="left">79</td><td align="left">(20.8)</td><td align="left"><italic>-</italic></td></tr><tr><td align="left">Education to junior college or higher</td><td align="left">112</td><td align="left">(24.5)</td><td align="left">111</td><td align="left">(24.3)</td><td align="left"><italic>0.962</italic></td></tr><tr><td align="left">Former and current smoker</td><td align="left">183</td><td align="left">(40.0)</td><td align="left">145</td><td align="left">(31.7)</td><td align="left"><italic>0.009</italic></td></tr><tr><td align="left">Occasional and regular alcohol consumption</td><td align="left">61</td><td align="left">(13.3)</td><td align="left">100</td><td align="left">(21.8)</td><td align="left"><italic>0.001</italic></td></tr><tr><td align="left">Moderate physical activity in the preceding 5 years</td><td align="left">50</td><td align="left">(10.9)</td><td align="left">79</td><td align="left">(17.3)</td><td align="left"><italic>0.006</italic></td></tr><tr><td align="left">&#x02265; 3 Live births</td><td align="left">199</td><td align="left">(43.5)</td><td align="left">238</td><td align="left">(52.0)</td><td align="left"><italic>0.034</italic></td></tr><tr><td align="left">Breast cancer in first-degree relative</td><td align="left">29</td><td align="left">(6.3)</td><td align="left">27</td><td align="left">(5.9)</td><td align="left"><italic>0.783</italic></td></tr><tr><td align="left">Breast feeding in all women</td><td align="left">353</td><td align="left">(77.1)</td><td align="left">368</td><td align="left">(80.4)</td><td align="left"><italic>0.452</italic></td></tr><tr><td align="left">Postmenopausal women</td><td align="left">274</td><td align="left">(59.8)</td><td align="left">289</td><td align="left">(63.1)</td><td align="left"><italic>0.309</italic></td></tr><tr><td align="left">Vitamin supplement use</td><td align="left">28</td><td align="left">(6.1)</td><td align="left">54</td><td align="left">(11.8)</td><td align="left"><italic>0.003</italic></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Energy-adjusted nutrient intake</td><td align="left" colspan="5">Mean &#x000b1; SD<sup>&#x02020;</sup></td></tr><tr><td align="left">&#x02003;Folate, &#x003bc;g/day</td><td align="left">544.8</td><td align="left">&#x000b1; 160.2</td><td align="left">529.4</td><td align="left">&#x000b1; 154.6</td><td align="left"><italic>0.140</italic></td></tr><tr><td align="left">&#x02003;Vitamin B<sub>6</sub>, mg/day</td><td align="left">0.9</td><td align="left">&#x000b1; 0.6</td><td align="left">0.9</td><td align="left">&#x000b1; 0.5</td><td align="left"><italic>0.143</italic></td></tr><tr><td align="left">&#x02003;Vitamin B<sub>12</sub>, &#x003bc;g/day</td><td align="left">7.5</td><td align="left">&#x000b1; 8.7</td><td align="left">7.0</td><td align="left">&#x000b1; 5.7</td><td align="left"><italic>0.260</italic></td></tr><tr><td align="left">Energy, kcal/day</td><td align="left">1815.5</td><td align="left">&#x000b1; 625.4</td><td align="left">1722.9</td><td align="left">&#x000b1; 593.6</td><td align="left"><italic>0.022</italic></td></tr></tbody></table><table-wrap-foot><p><sup>&#x02020;</sup>SD, standard deviation.</p><p>*Differences between case-control pairs in mean values were tested by the paired <italic>t </italic>test, and in proportions by the <italic>Cochran-Mantel-Haenszel </italic>test.</p></table-wrap-foot></table-wrap><sec><title>B Vitamins and Breast Cancer Risk</title><p>Using the lowest tertile intake of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>as reference, no statistically significant association was observed between vitamin intake and breast cancer risk in all women (Table <xref ref-type="table" rid="T2">2</xref>). Similar null results were found in Japanese and non-Japanese women, as well as in individuals who refrained from alcohol consumption or vitamin supplement use (data not shown). An increased risk was seen in premenopausal women in the highest tertile of folate intake (P for trend = 0.010) and in postmenopausal women in the highest tertile of vitamin B<sub>6 </sub>intake (P for trend = 0.047). Similarly, a statistically significant increase in risk was seen for high folate intake in premenopausal women of non-Japanese Brazilian ethnicity (in the highest tertile of folate intake, OR = 1.89, 95% CI = 1.06&#x02013;3.38; P for trend = 0.037), but not in those of Japanese-Brazilian ethnicity.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Association between energy-adjusted nutrient intake and breast cancer risk in Brazilian women</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td align="center" colspan="3">Total</td><td align="center" colspan="3">Premenopausal women</td><td align="center" colspan="3">Postmenopausal women</td></tr><tr><td></td><td></td><td colspan="9"><hr></hr></td></tr><tr><td align="left">Nutrient intake*</td><td align="center">Tertile</td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02020;</sup></td><td align="center">(95% CI)<sup>&#x02020;</sup></td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02021;</sup></td><td align="center">(95% CI)<sup>&#x02021;</sup></td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02021;</sup></td><td align="center">(95% CI)<sup>&#x02021;</sup></td></tr></thead><tbody><tr><td align="left">Folate (&#x003bc;g/day)</td><td align="center">&#x0003c;446.2</td><td align="center">140/152</td><td align="center">1.00</td><td align="center">-</td><td align="center">43/60</td><td align="center">1.00</td><td align="center">-</td><td align="center">97/92</td><td align="center">1.00</td><td align="center">-</td></tr><tr><td></td><td align="center">446.2-&#x0003c;602.2</td><td align="center">42/153</td><td align="center">1.05</td><td align="center">(0.75&#x02013;1.46)</td><td align="center">58/50</td><td align="center">1.73</td><td align="center">(0.97&#x02013;3.08)</td><td align="center">84/103</td><td align="center">0.77</td><td align="center">(0.50&#x02013;1.19)</td></tr><tr><td></td><td align="center">&#x02265; 602.2</td><td align="center">176/153</td><td align="center">1.26</td><td align="center">(0.89&#x02013;1.78)</td><td align="center">83/59</td><td align="center">2.17</td><td align="center">(1.23&#x02013;3.83)</td><td align="center">93/94</td><td align="center">0.91</td><td align="center">(0.59&#x02013;1.41)</td></tr><tr><td></td><td align="center"><italic>P trend</italic></td><td></td><td align="center"><italic>0.217</italic></td><td></td><td></td><td align="center"><italic>0.010</italic></td><td></td><td></td><td align="center"><italic>0.685</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Vitamin B<sub>6 </sub>(mg/day)</td><td align="center">&#x0003c;0.6</td><td align="center">145/152</td><td align="center">1.00</td><td align="center">-</td><td align="center">63/49</td><td align="center">1.00</td><td align="center">-</td><td align="center">82/103</td><td align="center">1.00</td><td align="center">-</td></tr><tr><td></td><td align="center">0.6&#x02013;&#x0003c;1.0</td><td align="center">148/153</td><td align="center">1.04</td><td align="center">(0.74&#x02013;1.46)</td><td align="center">57/54</td><td align="center">0.80</td><td align="center">(0.46&#x02013;1.39)</td><td align="center">91/99</td><td align="center">1.30</td><td align="center">(0.85&#x02013;1.98)</td></tr><tr><td></td><td align="center">&#x02265; 1.0</td><td align="center">165/153</td><td align="center">1.18</td><td align="center">(0.84&#x02013;1.65)</td><td align="center">64/66</td><td align="center">0.81</td><td align="center">(0.48&#x02013;1.37)</td><td align="center">101/87</td><td align="center">1.54</td><td align="center">(1.01&#x02013;2.35)</td></tr><tr><td></td><td align="center"><italic>P trend</italic></td><td></td><td align="center"><italic>0.384</italic></td><td></td><td></td><td align="center"><italic>0.418</italic></td><td></td><td></td><td align="center"><italic>0.047</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Vitamin B<sub>12 </sub>(&#x003bc;g/day)</td><td align="center">&#x0003c;3.9</td><td align="center">165/152</td><td align="center">1.00</td><td align="center">-</td><td align="center">61/49</td><td align="center">1.00</td><td align="center">-</td><td align="center">104/103</td><td align="center">1.00</td><td align="center">-</td></tr><tr><td></td><td align="center">3.9&#x02013;&#x0003c;7.3</td><td align="center">143/153</td><td align="center">0.90</td><td align="center">(0.64&#x02013;1.25)</td><td align="center">55/56</td><td align="center">0.77</td><td align="center">(0.45&#x02013;1.33)</td><td align="center">88/97</td><td align="center">0.96</td><td align="center">(0.64&#x02013;1.45)</td></tr><tr><td></td><td align="center">&#x02265; 7.3</td><td align="center">150/153</td><td align="center">0.90</td><td align="center">(0.65&#x02013;1.26)</td><td align="center">68/64</td><td align="center">0.83</td><td align="center">(0.49&#x02013;1.41)</td><td align="center">82/89</td><td align="center">1.00</td><td align="center">(0.65&#x02013;1.52)</td></tr><tr><td></td><td align="center"><italic>P trend</italic></td><td></td><td align="center"><italic>0.531</italic></td><td></td><td></td><td align="center"><italic>0.486</italic></td><td></td><td></td><td align="center"><italic>0.949</italic></td><td></td></tr></tbody></table><table-wrap-foot><p>*Energy-adjusted intakes were categorized among controls by tertiles of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>for total Brazilian women.</p><p><sup>&#x02020;</sup>Adjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1&#x02013;2/&#x02265;3).</p><p><sup>&#x02021;</sup>Adjusted for age group (20-/30-/40-/50-/60-/&#x02265;70), ethnicity (white/mixed/black/yellow), smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1&#x02013;2/&#x02265;3).</p></table-wrap-foot></table-wrap></sec><sec><title>Polymorphisms of <italic>MTHFR </italic>and <italic>MTR </italic>Genes and Breast Cancer Risk</title><p>Associations between polymorphisms of the <italic>MTHFR </italic>or <italic>MTR </italic>genes and breast cancer risk are shown in Table <xref ref-type="table" rid="T3">3</xref>. No deviation from the Hardy-Weinberg equilibrium was observed in the controls. Compared to the reference group, women with the <italic>MTR </italic>2756GG genotype had a significantly increased risk of breast cancer (OR = 1.99, 95% CI = 1.01&#x02013;3.92; P for trend = 0.801), but no other statistically significant associations were observed for all, pre-, or postmenopausal women. Similar null results were found in both non-Japanese and Japanese-Brazilian women (data not shown), although distribution of the <italic>MTHFR </italic>C677T polymorphism (CC, CT, and TT genotype) in control subjects differed significantly between the non-Japanese Brazilian (51%, 39%, and 10%, respectively) and Japanese-Brazilian women (35%, 52%, and 13%, respectively) (<italic>P </italic>= 0.038).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Association between genotype of related enzymes and breast cancer risk in Brazilian women</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Gene</td><td align="left">Allele</td><td align="center" colspan="3">Total</td><td align="center" colspan="3">Premenopausal women</td><td align="center" colspan="3">Postmenopausal women</td></tr><tr><td></td><td></td><td colspan="9"><hr></hr></td></tr><tr><td></td><td></td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02020;</sup></td><td align="center">(95% CI)<sup>&#x02020;</sup></td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02021;</sup></td><td align="center">(95% CI)<sup>&#x02021;</sup></td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02021;</sup></td><td align="center">(95% CI)<sup>&#x02021;</sup></td></tr></thead><tbody><tr><td align="left">MTHFR_AC</td><td align="left">AA</td><td align="center">269/279</td><td align="center">1.00</td><td align="center">-</td><td align="center">117/107</td><td align="center">1.00</td><td align="center">-</td><td align="center">152/172</td><td align="center">1.00</td><td align="center">-</td></tr><tr><td></td><td align="left">AC</td><td align="center">168/157</td><td align="center">1.11</td><td align="center">(0.83&#x02013;1.50)</td><td align="center">63/52</td><td align="center">1.09</td><td align="center">(0.68&#x02013;1.75)</td><td align="center">105/105</td><td align="center">1.11</td><td align="center">(0.77&#x02013;1.58)</td></tr><tr><td></td><td align="left">CC</td><td align="center">21/22</td><td align="center">1.03</td><td align="center">(0.51&#x02013;2.10)</td><td align="center">4/10</td><td align="center">0.39</td><td align="center">(0.11&#x02013;1.35)</td><td align="center">17/12</td><td align="center">1.96</td><td align="center">(0.88&#x02013;4.37)</td></tr><tr><td></td><td align="left"><italic>P trend</italic></td><td></td><td align="center"><italic>0.543</italic></td><td></td><td></td><td align="center"><italic>0.585</italic></td><td></td><td></td><td align="center"><italic>0.161</italic></td><td></td></tr><tr><td></td><td align="left">AC+CC</td><td align="center">189/179</td><td align="center">1.11</td><td align="center">(0.83&#x02013;1.48)</td><td align="center">67/62</td><td align="center">0.99</td><td align="center">(0.63&#x02013;1.55)</td><td align="center">122/117</td><td align="center">1.18</td><td align="center">(0.84&#x02013;1.67)</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_CT</td><td align="left">CC</td><td align="center">225/222</td><td align="center">1.00</td><td align="center">-</td><td align="center">93/86</td><td align="center">1.00</td><td align="center">-</td><td align="center">132/136</td><td align="center">1.00</td><td align="center">-</td></tr><tr><td></td><td align="left">CT</td><td align="center">188/187</td><td align="center">1.02</td><td align="center">(0.77&#x02013;1.36)</td><td align="center">75/68</td><td align="center">0.98</td><td align="center">(0.62&#x02013;1.56)</td><td align="center">113/119</td><td align="center">0.96</td><td align="center">(0.67&#x02013;1.38)</td></tr><tr><td></td><td align="left">TT</td><td align="center">45/49</td><td align="center">0.88</td><td align="center">(0.55&#x02013;1.42)</td><td align="center">16/15</td><td align="center">0.88</td><td align="center">(0.40&#x02013;1.95)</td><td align="center">29/34</td><td align="center">0.78</td><td align="center">(0.44&#x02013;1.38)</td></tr><tr><td></td><td align="left"><italic>P trend</italic></td><td></td><td align="center"><italic>0.743</italic></td><td></td><td></td><td align="center"><italic>0.789</italic></td><td></td><td></td><td align="center"><italic>0.515</italic></td><td></td></tr><tr><td></td><td align="left">CT+TT</td><td align="center">233/236</td><td align="center">0.99</td><td align="center">(0.76&#x02013;1.30)</td><td align="center">91/83</td><td align="center">0.96</td><td align="center">(0.62&#x02013;1.49)</td><td align="center">142/153</td><td align="center">0.92</td><td align="center">(0.65&#x02013;1.30)</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTR</td><td align="left">AA</td><td align="center">294/294</td><td align="center">1.00</td><td align="center">-</td><td align="center">118/105</td><td align="center">1.00</td><td align="center">-</td><td align="center">176/189</td><td align="center">1.00</td><td align="center">-</td></tr><tr><td></td><td align="left">AG</td><td align="center">135/149</td><td align="center">0.81</td><td align="center">(0.59&#x02013;1.10)</td><td align="center">53/56</td><td align="center">0.76</td><td align="center">(0.47&#x02013;1.23)</td><td align="center">82/93</td><td align="center">0.93</td><td align="center">(0.64&#x02013;1.35)</td></tr><tr><td></td><td align="left">GG</td><td align="center">28/15</td><td align="center">1.99</td><td align="center">(1.01&#x02013;3.92)</td><td align="center">13/8</td><td align="center">1.34</td><td align="center">(0.51&#x02013;3.51)</td><td align="center">15/7</td><td align="center">2.28</td><td align="center">(0.88&#x02013;5.90)</td></tr><tr><td></td><td align="left"><italic>P trend</italic></td><td></td><td align="center"><italic>0.801</italic></td><td></td><td></td><td align="center"><italic>0.738</italic></td><td></td><td></td><td align="center"><italic>0.543</italic></td><td></td></tr><tr><td></td><td align="left">AG+GG</td><td align="center">163/164</td><td align="center">0.92</td><td align="center">(0.68&#x02013;1.23)</td><td align="center">66/64</td><td align="center">0.83</td><td align="center">(0.53&#x02013;1.31)</td><td align="center">97/100</td><td align="center">1.02</td><td align="center">(0.71&#x02013;1.46)</td></tr></tbody></table><table-wrap-foot><p><sup>&#x02020;</sup>Adjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1&#x02013;2/&#x02265;3).</p><p><sup>&#x02021;</sup>Adjusted for age group (20-/30-/40-/50-/60-/&#x02265;70), ethnicity (white/mixed/black/yellow), smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1&#x02013;2/&#x02265;3).</p></table-wrap-foot></table-wrap><p>We also examined the effects of combined genotypes of <italic>MTHFR </italic>A1298C and C677T, <italic>MTHFR </italic>A1298C and <italic>MTR </italic>A2756G, and <italic>MTHFR </italic>C677T and <italic>MTR </italic>A2756G, none of which was statistically significantly associated with the risk of breast cancer compared to their wild genotypes.</p></sec><sec><title>Gene-environment Interactions in Breast Cancer</title><p>The joint effects of <italic>MTHFR </italic>and <italic>MTR </italic>polymorphisms and dietary intake on breast cancer risk are shown in Table <xref ref-type="table" rid="T4">4</xref>, in which the genotypes <italic>MTHFR </italic>1298AA and 677CC and <italic>MTR </italic>2756AA with the lowest tertiles of dietary intake were used as references, with variant allele combinations. Statistically significant positive associations between folate intake and breast cancer risk were observed among women with the <italic>MTHFR </italic>1298AA (P for trend = 0.003), 677CT and TT (P for trend = 0.011), and <italic>MTR </italic>2756AA genotypes (P for trend = 0.049). An increased risk of breast cancer was seen in those women with the lowest folate intake who had the <italic>MTHFR </italic>1298AC and CC genotype (OR = 1.95, 95% CI = 1.18&#x02013;3.22). In contrast, a decreased risk was seen in those women with the lowest folate intake who had the <italic>MTHFR </italic>677CT and TT genotype (OR = 0.60, 95% CI = 0.37&#x02013;0.97). Statistically significant interactions were detected for folate intake with <italic>MTHFR </italic>A1298C (P for interaction = 0.024) and C677T polymorphisms (P for interaction = 0.043).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Combined effects of genotype of related enzymes and energy-adjusted nutrient intakes in all breast cancer cases and controls in Brazilian women</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Gene</td><td align="left">Allele</td><td align="center" colspan="3">Tertile 1 (lower)*</td><td align="center" colspan="3">Tertile 2</td><td align="center" colspan="3">Tertile 3</td><td align="center"><italic>P</italic><sub><italic>trend</italic></sub></td><td align="center"><italic>P</italic><sub><italic>interaction</italic></sub></td></tr><tr><td></td><td></td><td colspan="9"><hr></hr></td><td></td><td></td></tr><tr><td></td><td></td><td align="center">Case/Control</td><td align="center">OR<sup>&#x02020;</sup></td><td align="center">(95%CI)<sup>&#x02020;</sup></td><td align="center">Case/Control</td><td align="center">OR</td><td align="center">(95%CI)</td><td align="center">Case/Control</td><td align="center">OR</td><td align="center">(95%CI)</td><td></td><td></td></tr></thead><tbody><tr><td align="left">Folate</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_AC</td><td align="left">AA</td><td align="center">72/105</td><td align="center">1.00</td><td align="center">-</td><td align="center">87/89</td><td align="center">1.40</td><td align="center">(0.92&#x02013;2.14)</td><td align="center">110/85</td><td align="center">1.76</td><td align="center">(1.14&#x02013;2.72)</td><td align="center"><italic>0.003</italic></td><td align="center"><italic>0.024</italic></td></tr><tr><td></td><td align="left">AC+CC</td><td align="center">68/47</td><td align="center">1.95</td><td align="center">(1.18&#x02013;3.22)</td><td align="center">55/64</td><td align="center">1.31</td><td align="center">(0.79&#x02013;2.17)</td><td align="center">66/68</td><td align="center">1.45</td><td align="center">(0.88&#x02013;2.41)</td><td align="center"><italic>0.109</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_CT</td><td align="left">CC</td><td align="center">73/60</td><td align="center">1.00</td><td align="center">-</td><td align="center">62/75</td><td align="center">0.72</td><td align="center">(0.44&#x02013;1.17)</td><td align="center">90/87</td><td align="center">0.84</td><td align="center">(0.52&#x02013;1.37)</td><td align="center"><italic>0.417</italic></td><td align="center"><italic>0.043</italic></td></tr><tr><td></td><td align="left">CT+TT</td><td align="center">67/92</td><td align="center">0.60</td><td align="center">(0.37&#x02013;0.97)</td><td align="center">80/78</td><td align="center">0.86</td><td align="center">(0.53&#x02013;1.40)</td><td align="center">86/66</td><td align="center">1.08</td><td align="center">(0.66&#x02013;1.77)</td><td align="center"><italic>0.011</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTR</td><td align="left">AA</td><td align="center">86/101</td><td align="center">1.00</td><td align="center">-</td><td align="center">95/102</td><td align="center">1.14</td><td align="center">(0.75&#x02013;1.72)</td><td align="center">113/91</td><td align="center">1.56</td><td align="center">(1.01&#x02013;2.43)</td><td align="center"><italic>0.049</italic></td><td align="center"><italic>0.283</italic></td></tr><tr><td></td><td align="left">AG+GG</td><td align="center">54/51</td><td align="center">1.21</td><td align="center">(0.73&#x02013;2.00)</td><td align="center">46/51</td><td align="center">1.12</td><td align="center">(0.66&#x02013;1.90)</td><td align="center">63/62</td><td align="center">1.07</td><td align="center">(0.65&#x02013;1.77)</td><td align="center"><italic>0.574</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Vitamin B<sub>6</sub></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_AC</td><td align="left">AA</td><td align="center">73/82</td><td align="center">1.00</td><td align="center">-</td><td align="center">85/106</td><td align="center">0.99</td><td align="center">(0.63&#x02013;1.55)</td><td align="center">111/91</td><td align="center">1.50</td><td align="center">(0.95&#x02013;2.37)</td><td align="center"><italic>0.061</italic></td><td align="center"><italic>0.043</italic></td></tr><tr><td></td><td align="left">CA+CC</td><td align="center">72/70</td><td align="center">1.28</td><td align="center">(0.79&#x02013;2.06)</td><td align="center">63/47</td><td align="center">1.56</td><td align="center">(0.92&#x02013;2.63)</td><td align="center">54/62</td><td align="center">1.02</td><td align="center">(0.61&#x02013;1.72)</td><td align="center"><italic>0.669</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_CT</td><td align="left">CC</td><td align="center">78/68</td><td align="center">1.00</td><td align="center">-</td><td align="center">68/75</td><td align="center">0.80</td><td align="center">(0.48&#x02013;1.33)</td><td align="center">79/79</td><td align="center">0.90</td><td align="center">(0.55&#x02013;1.48)</td><td align="center"><italic>0.914</italic></td><td align="center"><italic>0.273</italic></td></tr><tr><td></td><td align="left">CT+TT</td><td align="center">67/84</td><td align="center">0.71</td><td align="center">(0.43&#x02013;1.16)</td><td align="center">80/78</td><td align="center">0.91</td><td align="center">(0.56&#x02013;1.46)</td><td align="center">86/74</td><td align="center">1.03</td><td align="center">(0.64&#x02013;1.67)</td><td align="center"><italic>0.105</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTR</td><td align="left">AA</td><td align="center">91/95</td><td align="center">1.00</td><td align="center">-</td><td align="center">98/100</td><td align="center">1.04</td><td align="center">(0.67&#x02013;1.61)</td><td align="center">105/99</td><td align="center">1.18</td><td align="center">(0.77&#x02013;1.81)</td><td align="center"><italic>0.435</italic></td><td align="center"><italic>1.000</italic></td></tr><tr><td></td><td align="left">AG+GG</td><td align="center">54/57</td><td align="center">0.92</td><td align="center">(0.57&#x02013;1.50)</td><td align="center">50/53</td><td align="center">0.95</td><td align="center">(0.57&#x02013;1.59)</td><td align="center">59/54</td><td align="center">1.07</td><td align="center">(0.64&#x02013;1.79)</td><td align="center"><italic>0.538</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Vitamin B<sub>12</sub></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_AC</td><td align="left">AA</td><td align="center">96/94</td><td align="center">1.00</td><td align="center">-</td><td align="center">76/96</td><td align="center">0.78</td><td align="center">(0.50&#x02013;1.20)</td><td align="center">97/89</td><td align="center">1.10</td><td align="center">(0.72&#x02013;1.68)</td><td align="center"><italic>0.662</italic></td><td align="center"><italic>0.088</italic></td></tr><tr><td></td><td align="left">CA+CC</td><td align="center">69/58</td><td align="center">1.23</td><td align="center">(0.76&#x02013;2.00)</td><td align="center">67/57</td><td align="center">1.22</td><td align="center">(0.77&#x02013;1.96)</td><td align="center">53/64</td><td align="center">0.79</td><td align="center">(0.49&#x02013;1.30)</td><td align="center"><italic>0.167</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTHFR_CT</td><td align="left">CC</td><td align="center">83/70</td><td align="center">1.00</td><td align="center">-</td><td align="center">79/70</td><td align="center">0.90</td><td align="center">(0.55&#x02013;1.47)</td><td align="center">63/82</td><td align="center">0.59</td><td align="center">(0.36&#x02013;0.97)</td><td align="center"><italic>0.073</italic></td><td align="center"><italic>0.022</italic></td></tr><tr><td></td><td align="left">CT+TT</td><td align="center">82/82</td><td align="center">0.76</td><td align="center">(0.46&#x02013;1.24)</td><td align="center">64/83</td><td align="center">0.62</td><td align="center">(0.37&#x02013;1.05)</td><td align="center">87/71</td><td align="center">1.00</td><td align="center">(0.63&#x02013;1.60)</td><td align="center"><italic>0.349</italic></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">MTR</td><td align="left">AA</td><td align="center">105/94</td><td align="center">1.00</td><td align="center">-</td><td align="center">94/105</td><td align="center">0.79</td><td align="center">(0.52&#x02013;1.20)</td><td align="center">95/95</td><td align="center">0.90</td><td align="center">(0.59&#x02013;1.38)</td><td align="center"><italic>0.560</italic></td><td align="center"><italic>0.592</italic></td></tr><tr><td></td><td align="left">AG+GG</td><td align="center">60/58</td><td align="center">0.81</td><td align="center">(0.51&#x02013;1.31)</td><td align="center">48/48</td><td align="center">0.92</td><td align="center">(0.54&#x02013;1.57)</td><td align="center">55/58</td><td align="center">0.76</td><td align="center">(0.47&#x02013;1.23)</td><td align="center"><italic>0.923</italic></td><td></td></tr></tbody></table><table-wrap-foot><p>*Energy-adjusted intakes were categorized among controls by tertiles of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12</sub>, respectively.</p><p><sup>&#x02020;</sup>Adjusted for smoking status (never/ever), alcohol consumption (never/ever), moderate physical activity in the preceding 5 years (no/yes), and number of live births (nulliparous/1&#x02013;2/&#x02265;3).</p></table-wrap-foot></table-wrap><p>A marginally positive association was observed between the highest tertile of vitamin B<sub>6 </sub>intake and breast cancer risk among women with the <italic>MTHFR </italic>1298AA genotype (P for trend = 0.061), whereas an inverse association was observed between the highest tertile of vitamin B<sub>12 </sub>intake and breast cancer risk among those with the <italic>MTHFR </italic>677CC genotype (P for trend = 0.073). A statistically significant interaction was detected between the <italic>MTHFR </italic>A1298C polymorphism and vitamin B<sub>6 </sub>intake (P for interaction = 0.043) and between the <italic>MTHFR </italic>C677T polymorphism and vitamin B<sub>12 </sub>intake (P for interaction = 0.022).</p></sec></sec><sec><title>Discussion</title><p>In this study, we found no overall association between folate, vitamin B<sub>6, </sub>and vitamin B<sub>12 </sub>intake and the risk of breast cancer. These findings are consistent with previous studies on folate [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B40">40</xref>], vitamin B<sub>6 </sub>[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>], and vitamin B<sub>12 </sub>[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>].</p><p>Generally, folate is able to prevent the development of tumors before preneoplastic lesions have been established, but conversely increases tumorigenesis once lesions have been established [<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. Although increased folate intake may be beneficial in populations deficient in this nutrient, increased intake in women with already-sufficient levels of folate may provide no further benefit, or actually be harmful [<xref ref-type="bibr" rid="B34">34</xref>]. Folate intake in Brazilian women in the present study (inter-tertile range, 446.2&#x02013;602.2 &#x003bc;g/day) was higher than that measured in a study of Japanese women (inter-tertile range, 386&#x02013;501 &#x003bc;g/day) [<xref ref-type="bibr" rid="B28">28</xref>] and in a meta-analysis of Caucasian and Asian women (inter-tertile range, 77&#x02013;255 to 147&#x02013;359 &#x003bc;g/day and 132&#x02013;304 to 206&#x02013;473 &#x003bc;g/day) [<xref ref-type="bibr" rid="B2">2</xref>]. In this study, we observed an increased risk of breast cancer in premenopausal women with high folate intake. Folate levels may have been already sufficient in the lower intake group, and thus an increase in intake may on this basis have contributed to tumorigenesis.</p><p>Similarly, a study on plasma folate found that concentration was associated with an increase in breast cancer risk in premenopausal but not in postmenopausal women [<xref ref-type="bibr" rid="B39">39</xref>]. This study also indicated that the proliferation rate of breast epithelial cells may be higher in premenopausal than postmenopausal women, leaving less time for DNA repair in premenopausal women [<xref ref-type="bibr" rid="B39">39</xref>]. Further, a large population-based case-control study reported that high dietary vitamin B<sub>6 </sub>intake was associated with an increased risk of breast cancer, but did not indicate the menopausal status of participants [<xref ref-type="bibr" rid="B8">8</xref>]. In contrast, another study found a decreased risk of breast cancer in postmenopausal women with high plasma levels of vitamin B<sub>6 </sub>[<xref ref-type="bibr" rid="B39">39</xref>]. Our finding of a significant increase in breast cancer risk in postmenopausal women due to vitamin B<sub>6 </sub>intake may thus be due to chance.</p><p>A Canadian study found that a high total folate intake, obtained mainly from nutritional supplements, significantly increased breast cancer risk by 32% (highest &#x0003e;853 &#x003bc;g/day versus lowest quintile &#x02264;336 &#x003bc;g/day) in postmenopausal women [<xref ref-type="bibr" rid="B33">33</xref>]. The authors hypothesized that high folic acid concentrations may contribute to epigenetic changes in gene-regulatory mechanisms, which may result in gene silencing and enhanced cancer development, or may promote the growth of tumors expressing folate receptors [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B41">41</xref>]. However, the mechanism of this effect remains unclear [<xref ref-type="bibr" rid="B41">41</xref>]. In our study, however, overall vitamin supplement users (defined as more than once-weekly use for at least one year) accounted for 11.8% of controls, and the distribution of supplement users was similar in the highest and lowest intake groups (data not shown). Because folate and other B vitamin intake in our population was thus obtained primarily from unfortified diets, the increased risk of breast cancer in premenopausal women with high folate intake was unlikely due to supplement use.</p><p>A recent meta-analysis indicated no overall significant association between the <italic>MTHFR </italic>C677T polymorphism and breast cancer risk in Caucasians and East Asians, or between the <italic>MTHFR </italic>A1298C polymorphism and risk in Caucasians [<xref ref-type="bibr" rid="B27">27</xref>]. Our study supports the lack of association found in this meta-analysis as well as in others studies in Caucasian and Asian women [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. In contrast to another finding of the meta-analysis [<xref ref-type="bibr" rid="B27">27</xref>], however, which found an increased risk of breast cancer in premenopausal women with the <italic>MTHFR </italic>677CT and TT genotype compared to those with the CC genotype, we did not observe any increase in risk in these groups. Further, contrary to the findings in a previous study conducted in Americans [<xref ref-type="bibr" rid="B1">1</xref>], we did not find an increased risk of breast cancer to be related to the genotype combination of <italic>MTHFR </italic>A1298C and C677T. This lack of concordance in findings may be due to the low proportion of the <italic>MTHFR </italic>677T genotype in our study population or to compensation by the folate-replete status of patients for the effects of the variant alleles of the <italic>MTHFR </italic>A1298C and C677T genotypes [<xref ref-type="bibr" rid="B2">2</xref>]. Nevertheless, few studies have achieved conclusive results regarding whether functional polymorphisms in one-carbon metabolizing genes affect breast cancer risk associated with dietary intake of folate and other related B vitamins, the biological plausibility of this scenario notwithstanding [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>The <italic>MTR </italic>gene contributes to alterations in the plasma levels of homocysteine and folate; specifically, subjects with the 2756AG and GG genotypes have lower levels of plasma homocysteine or higher levels of serum folate than those with the 2756AA genotype [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. When methionine levels are adequate, these variant polymorphisms with lower enzyme activity may also result in elevated homocysteine levels and DNA hypomethylation [<xref ref-type="bibr" rid="B46">46</xref>]. A Polish study reported the possible association between the hetero- and homozygote variants of the <italic>MTR </italic>A2756G and a decreased risk of breast cancer [<xref ref-type="bibr" rid="B6">6</xref>]. In the present study, however, we observed an increased risk of breast cancer in total subjects who had the MTR 2756GG genotype, a finding similar to that reported in a recent study conducted in Taiwan [<xref ref-type="bibr" rid="B46">46</xref>]. This observed increase may be due to the linkage between the <italic>MTR </italic>A2756G polymorphism and other genetic polymorphisms, or to the interaction between the <italic>MTR </italic>A2756G polymorphism and other genetic polymorphisms related to folate metabolism, such as that for methionine synthase reductase (<italic>MTRR </italic>G66A) [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B45">45</xref>], cytosolic serine hydroxymethyltransferase (<italic>cSHMT </italic>C1420T) [<xref ref-type="bibr" rid="B21">21</xref>], or <italic>MTHFR </italic>C677T [<xref ref-type="bibr" rid="B47">47</xref>]. However, we observed no statistically significant associations between the combined genotypes of <italic>MTR </italic>A2756G and either <italic>MTHFR </italic>A1298C or C667T and breast cancer risk, nor could we test the joint effects of <italic>MTR </italic>with <italic>MTRR </italic>or <italic>cSHMT </italic>genes since <italic>MTRR </italic>and <italic>cSHMT </italic>genes were not available in the present study. Given the low frequency of the <italic>MTR </italic>2756GG genotype in our study population, the significant finding of our present study may be the result of chance.</p><p>Previous authors have speculated that interactions between folate and <italic>MTHFR </italic>polymorphism may be elicited to show that (a) the lower activity of variant genotypes may increase the risk of breast cancer at low levels of dietary folate since less 5-methyl THF is made available for DNA methylation, and (b) variant genotypes might provide advantages over the wild genotype in folate-replete conditions since 5,10-methyl THF would be available for nucleotide synthesis [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Supporting notion (a), we found an increased risk of breast cancer among women with the lowest folate intake who had the <italic>MTHFR </italic>1298AC and CC genotype. Contrary to (a), however, we also saw a decrease in breast cancer risk among women with the lowest folate intake who had the <italic>MTHFR </italic>677CT and TT genotype. Similar findings of decreased breast cancer risk in variant <italic>MTHFR </italic>C677T genotypes have been reported in previous studies in German [<xref ref-type="bibr" rid="B5">5</xref>], Japanese-American [<xref ref-type="bibr" rid="B20">20</xref>], and Chinese patients [<xref ref-type="bibr" rid="B10">10</xref>]. The reduced activity of the <italic>MTHFR </italic>C677T polymorphism was speculated to increase the pool of intracellular 5,10-methylene THF, which protects against potential defects in DNA synthesis, although circulating folate levels (5-methyl THF) tended to be lower [<xref ref-type="bibr" rid="B10">10</xref>]. Nevertheless, the inconsistencies in results between this and previous studies may be due to differences in ethnicity [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B19">19</xref>], background dietary status [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B37">37</xref>], or possibly chance. Given the above discussion regarding folate intake level, the increased risk of breast cancer observed here in patients with the <italic>MTHFR </italic>1298AA and <italic>MTR </italic>2756AA genotype in a higher tertile of folate intake may be due to the harmful effects brought about by excessive intake of folate. Notion (b) suggests that the lower activity of variant alleles of <italic>MTHFR </italic>A1298C provides advantages over the <italic>MTHFR </italic>1298AA genotype, but with the compensation of sufficient folate intake, the lower enzyme activity was attenuated to result in the lack of significant association seen with the variant <italic>MTHFR </italic>A1298C genotypes in the higher category of folate intake. In addition, the observed trend to a decline in breast cancer risk with increased vitamin B<sub>12 </sub>intake (P for trend = 0.073) and significant interaction between vitamin B<sub>12 </sub>and <italic>MTHFR </italic>C677T polymorphism might be due to the function of vitamin B<sub>12 </sub>as a cofactor in folate metabolisms [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B19">19</xref>].</p><p>Several limitations of this study warrant mention. First, dietary intake of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12 </sub>was assessed after breast cancer diagnosis and was therefore sensitive to recall bias. Case subjects may have been more motivated to recall diet than controls, and their recall may also have been inaccurate, depending on the belief of an association between diet and their disease. Second, although substantially high participation rates among both eligible case and control subjects minimized potential selection bias, the use of cancer-free patients as controls, whose dietary habits may have differed from the general population due to health consciousness or disease concerns, might have lead to selection bias. Third, as our subjects were recruited from eight hospitals in S&#x000e3;o Paulo, Brazil, they may not necessarily be representative of the general Brazilian population, and thus any extrapolation of results to the general population should be done cautiously. Fourth, our validation study found relatively low correlation coefficients between FFQ and DR-based nutrient intake estimates. Further, the validation study indicated that measurement errors in assessing nutrient intake by FFQ were unavoidable, although such random errors tend to result in null associations [<xref ref-type="bibr" rid="B48">48</xref>]. Fifth, although our quality control assessment of the genotyping showed high concordance rates between Genetic Lab. and our laboratory, we did not genotype the duplicate blinded samples of SNPs used in the present study and therefore cannot rule out the possibility of misclassification in genotyping status, although its effect on the results might be minimal. Sixth, stratified analyses were performed based on a relatively small number of cases, possibly limiting the interpretability of our results.</p></sec><sec><title>Conclusion</title><p>In this case-control study conducted in Brazilian women, we found no overall significant associations between dietary intake of folate, vitamin B<sub>6</sub>, and vitamin B<sub>12</sub>, <italic>MTHFR </italic>genotype, and breast cancer risk. However, we did identify an increased risk of breast cancer in total women with the <italic>MTR </italic>2756GG genotype, increased risk associated with higher folate intake in premenopausal women, and gene-nutrient interactions. Further studies into these factors will help to elucidate the etiology of breast cancer.</p></sec><sec><title>Abbreviations</title><p>CI: confidence interval; FFQ: food frequency questionnaire; MTHFR: 5,10-methylenetetrahydrofolate reductase; MTR: methionine synthase; OR: odds ratio; SNPs: single-nucleotide polymorphisms.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>EM performed the data analysis and drafted the manuscript. MI participated in the study design, coordinated the study and helped with data integrity, analysis, interpretation, and preparation of the manuscript. JI participated in data analysis and interpretation of data. GH involved the study design, supervised the study, contributed to data acquisition and interpretation. IN involved the study design, and contributed to data acquisition and interpretation. SC contributed to data acquisition and interpretation. JM contributed to data acquisition and interpretation. FL contributed to data acquisition and interpretation. ST designed, supervised and coordinated the study and helped with data interpretation and preparation of the manuscript. All authors have read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/9/122/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This study was supported by a Grant-in-Aid for Research on Risk of Chemical Substances from the Ministry of Health, Labour and Welfare of Japan, and Grants-in-Aid for Scientific Research on Priority Areas (17015049) and for Young Scientists (B) (17790378 and 19790415) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Japan Society for the Promotion of Science.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>VL</given-names></name><name><surname>McCullough</surname><given-names>ML</given-names></name><name><surname>Pavluck</surname><given-names>AL</given-names></name><name><surname>Talbot</surname><given-names>JT</given-names></name><name><surname>Feigelson</surname><given-names>HS</given-names></name><name><surname>Thun</surname><given-names>MJ</given-names></name><name><surname>Calle</surname><given-names>EE</given-names></name></person-group><article-title>Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2007</year><volume>16</volume><fpage>1140</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17548676</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-06-1037</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>SJ</given-names></name><name><surname>Harbord</surname><given-names>RM</given-names></name><name><surname>Harris</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name></person-group><article-title>Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk</article-title><source>J Natl Cancer Inst</source><year>2006</year><volume>98</volume><fpage>1607</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17105984</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Mason</surname><given-names>JB</given-names></name></person-group><article-title>Folate and carcinogenesis: an integrated scheme</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><fpage>129</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">10720158</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gammon</surname><given-names>MD</given-names></name><name><surname>Chan</surname><given-names>W</given-names></name><name><surname>Palomeque</surname><given-names>C</given-names></name><name><surname>Wetmur</surname><given-names>JG</given-names></name><name><surname>Kabat</surname><given-names>GC</given-names></name><name><surname>Teitelbaum</surname><given-names>SL</given-names></name><name><surname>Britton</surname><given-names>JA</given-names></name><name><surname>Terry</surname><given-names>MB</given-names></name><name><surname>Neugut</surname><given-names>AI</given-names></name><name><surname>Santella</surname><given-names>RM</given-names></name></person-group><article-title>One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><fpage>1606</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15735051</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2630</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Justenhoven</surname><given-names>C</given-names></name><name><surname>Hamann</surname><given-names>U</given-names></name><name><surname>Pierl</surname><given-names>CB</given-names></name><name><surname>Rabstein</surname><given-names>S</given-names></name><name><surname>Pesch</surname><given-names>B</given-names></name><name><surname>Harth</surname><given-names>V</given-names></name><name><surname>Baisch</surname><given-names>C</given-names></name><name><surname>Vollmert</surname><given-names>C</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Br&#x000fc;ning</surname><given-names>T</given-names></name><name><surname>Ko</surname><given-names>Y</given-names></name><name><surname>Brauch</surname><given-names>H</given-names></name></person-group><article-title>One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2005</year><volume>14</volume><fpage>3015</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16365030</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0592</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lissowska</surname><given-names>J</given-names></name><name><surname>Gaudet</surname><given-names>MM</given-names></name><name><surname>Brinton</surname><given-names>LA</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Peplonska</surname><given-names>B</given-names></name><name><surname>Welch</surname><given-names>R</given-names></name><name><surname>Zatonski</surname><given-names>W</given-names></name><name><surname>Szeszenia-Dabrowska</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Sherman</surname><given-names>M</given-names></name><name><surname>Garcia-Closas</surname><given-names>M</given-names></name></person-group><article-title>Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses</article-title><source>Int J Cancer</source><year>2007</year><volume>120</volume><fpage>2696</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">17311260</pub-id><pub-id pub-id-type="doi">10.1002/ijc.22604</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name></person-group><article-title>Re: dietary folate consumption and breast cancer risk</article-title><source>J Natl Cancer Inst</source><year>2000</year><volume>92</volume><fpage>1270</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">10922415</pub-id><pub-id pub-id-type="doi">10.1093/jnci/92.15.1270-a</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shrubsole</surname><given-names>MJ</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Potter</surname><given-names>JD</given-names></name><name><surname>Hebert</surname><given-names>JR</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group><article-title>Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>7136</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">11585746</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>F</given-names></name><name><surname>Pasche</surname><given-names>C</given-names></name><name><surname>Lucchini</surname><given-names>F</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>Dietary intake of selected micronutrients and breast-cancer risk</article-title><source>Int J Cancer</source><year>2001</year><volume>91</volume><fpage>260</fpage><lpage>3</lpage><ext-link ext-link-type="uri" xlink:href="http://www3.interscience.wiley.com/journal/76502470/abstract"/><pub-id pub-id-type="pmid">11146455</pub-id><pub-id pub-id-type="doi">10.1002/1097-0215(200002)9999:9999&#x0003c;::AID-IJC1041&#x0003e;3.3.CO;2-R</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>YC</given-names></name><name><surname>Wu</surname><given-names>MH</given-names></name><name><surname>Yu</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Shih</surname><given-names>HL</given-names></name><name><surname>Wu</surname><given-names>TY</given-names></name><name><surname>Sun</surname><given-names>CA</given-names></name></person-group><article-title>Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan</article-title><source>Carcinogenesis</source><year>2006</year><volume>27</volume><fpage>2295</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">16777985</pub-id><pub-id pub-id-type="doi">10.1093/carcin/bgl108</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adzersen</surname><given-names>KH</given-names></name><name><surname>Jess</surname><given-names>P</given-names></name><name><surname>Freivogel</surname><given-names>KW</given-names></name><name><surname>Gerhard</surname><given-names>I</given-names></name><name><surname>Bastert</surname><given-names>G</given-names></name></person-group><article-title>Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany</article-title><source>Nutr Cancer</source><year>2003</year><volume>46</volume><fpage>131</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14690788</pub-id><pub-id pub-id-type="doi">10.1207/S15327914NC4602_05</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lajous</surname><given-names>M</given-names></name><name><surname>Lazcano-Ponce</surname><given-names>E</given-names></name><name><surname>Hernandez-Avila</surname><given-names>M</given-names></name><name><surname>Willett</surname><given-names>W</given-names></name><name><surname>Romieu</surname><given-names>I</given-names></name></person-group><article-title>Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2006</year><volume>15</volume><fpage>443</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16537699</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0532</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>SM</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Giovannucci</surname><given-names>EL</given-names></name><name><surname>Holmes</surname><given-names>MD</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name></person-group><article-title>Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer</article-title><source>J Natl Cancer Inst</source><year>2003</year><volume>95</volume><fpage>373</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">12618502</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Hunter</surname><given-names>DJ</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name><name><surname>Giovannucci</surname><given-names>EL</given-names></name><name><surname>Rosner</surname><given-names>BA</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>A prospective study of folate intake and the risk of breast cancer</article-title><source>JAMA</source><year>1999</year><volume>281</volume><fpage>1632</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10235158</pub-id><pub-id pub-id-type="doi">10.1001/jama.281.17.1632</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lajous</surname><given-names>M</given-names></name><name><surname>Romieu</surname><given-names>I</given-names></name><name><surname>Sabia</surname><given-names>S</given-names></name><name><surname>Boutron-Ruault</surname><given-names>MC</given-names></name><name><surname>Clavel-Chapelon</surname><given-names>F</given-names></name></person-group><article-title>Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women</article-title><source>Cancer Causes Control</source><year>2006</year><volume>17</volume><fpage>1209</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">17006726</pub-id><pub-id pub-id-type="doi">10.1007/s10552-006-0053-3</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname><given-names>SC</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><name><surname>Wolk</surname><given-names>A</given-names></name></person-group><article-title>Folate and risk of breast cancer: a meta-analysis</article-title><source>J Natl Cancer Inst</source><year>2007</year><volume>99</volume><fpage>64</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">17202114</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>IG</given-names></name><name><surname>Baxter</surname><given-names>SW</given-names></name><name><surname>Eccles</surname><given-names>DM</given-names></name><name><surname>Choong</surname><given-names>DY</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer</article-title><source>Breast Cancer Res</source><year>2002</year><volume>4</volume><fpage>R14</fpage><pub-id pub-id-type="pmid">12473175</pub-id><pub-id pub-id-type="doi">10.1186/bcr457</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shrubsole</surname><given-names>MJ</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Cai</surname><given-names>QY</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group><article-title>MTR and MTRR Polymorphisms, Dietary Intake, and Breast Cancer Risk</article-title><source>Caner Epidemiol Biomarkers Prev</source><year>2006</year><volume>15</volume><fpage>586</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0576</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shrubsole</surname><given-names>MJ</given-names></name><name><surname>Gao</surname><given-names>YT</given-names></name><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Shu</surname><given-names>XO</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>H&#x000e9;bert</surname><given-names>JR</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name></person-group><article-title>MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2004</year><volume>13</volume><fpage>190</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14973091</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-03-0273</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Haiman</surname><given-names>CA</given-names></name><name><surname>Wilkens</surname><given-names>LR</given-names></name><name><surname>Kolonel</surname><given-names>LN</given-names></name><name><surname>Henderson</surname><given-names>BE</given-names></name></person-group><article-title>MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2004</year><volume>13</volume><fpage>2071</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15598763</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>CW</given-names></name><name><surname>Yu</surname><given-names>JC</given-names></name><name><surname>Huang</surname><given-names>CS</given-names></name><name><surname>Shieh</surname><given-names>JC</given-names></name><name><surname>Fu</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>HW</given-names></name><name><surname>Wu</surname><given-names>PE</given-names></name><name><surname>Shen</surname><given-names>CY</given-names></name></person-group><article-title>Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan</article-title><source>Breast Cancer Res Treat</source><year>2008</year><volume>111</volume><fpage>145</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">17896178</pub-id><pub-id pub-id-type="doi">10.1007/s10549-007-9754-x</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langsenlehner</surname><given-names>T</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><name><surname>Yazdani-Biuki</surname><given-names>B</given-names></name><name><surname>Langsenlehner</surname><given-names>U</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis</article-title><source>Breast Cancer Res Treat</source><year>2008</year><volume>107</volume><fpage>459</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17453338</pub-id><pub-id pub-id-type="doi">10.1007/s10549-007-9564-1</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macis</surname><given-names>D</given-names></name><name><surname>Maisonneuve</surname><given-names>P</given-names></name><name><surname>Johansson</surname><given-names>H</given-names></name><name><surname>Bonanni</surname><given-names>B</given-names></name><name><surname>Botteri</surname><given-names>E</given-names></name><name><surname>Iodice</surname><given-names>S</given-names></name><name><surname>Santillo</surname><given-names>B</given-names></name><name><surname>Penco</surname><given-names>S</given-names></name><name><surname>Gucciardo</surname><given-names>G</given-names></name><name><surname>D'Aiuto</surname><given-names>G</given-names></name><name><surname>Rosselli Del Turco</surname><given-names>M</given-names></name><name><surname>Amadori</surname><given-names>M</given-names></name><name><surname>Costa</surname><given-names>A</given-names></name><name><surname>Decensi</surname><given-names>A</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis</article-title><source>Breast Cancer Res Treat</source><year>2007</year><volume>106</volume><fpage>263</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17260091</pub-id><pub-id pub-id-type="doi">10.1007/s10549-006-9491-6</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakubowska</surname><given-names>A</given-names></name><name><surname>Gronwald</surname><given-names>J</given-names></name><name><surname>Menkiszak</surname><given-names>J</given-names></name><name><surname>G&#x000f3;rski</surname><given-names>B</given-names></name><name><surname>Huzarski</surname><given-names>T</given-names></name><name><surname>Byrski</surname><given-names>T</given-names></name><name><surname>Edler</surname><given-names>L</given-names></name><name><surname>Lubi&#x000f1;ski</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>RJ</given-names></name><name><surname>Hamann</surname><given-names>U</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks</article-title><source>Breast Cancer Res Treat</source><year>2007</year><volume>104</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">17063264</pub-id><pub-id pub-id-type="doi">10.1007/s10549-006-9417-3</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Hirose</surname><given-names>K</given-names></name><name><surname>Hiraki</surname><given-names>A</given-names></name><name><surname>Kawase</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Iwata</surname><given-names>H</given-names></name><name><surname>Tajima</surname><given-names>K</given-names></name></person-group><article-title>One-carbon metabolism-related gene polymorphisms and risk of breast cancer</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>356</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18174236</pub-id><pub-id pub-id-type="doi">10.1093/carcin/bgm295</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>JB</given-names></name></person-group><article-title>Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism</article-title><source>J Nutr</source><year>2003</year><volume>133</volume><fpage>941S</fpage><lpage>947S</lpage><pub-id pub-id-type="pmid">12612180</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zintzaras</surname><given-names>E</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis</article-title><source>Clin Genet</source><year>2006</year><volume>69</volume><fpage>327</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">16630166</pub-id><pub-id pub-id-type="doi">10.1111/j.1399-0004.2006.00605.x</pub-id></citation></ref><ref id="B28"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>E</given-names></name><name><surname>Iwasaki</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Kasuga</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>S</given-names></name><name><surname>Onuma</surname><given-names>H</given-names></name><name><surname>Nishimura</surname><given-names>H</given-names></name><name><surname>Kusama</surname><given-names>R</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name></person-group><article-title>Dietary Intake of Folate, Vitamin B2, Vitamin B6, and Vitamin B12, Genetic Polymorphism of Related Enzymes, and Risk of Breast Cancer: a Case-control Study in Japan</article-title><source>Nutr Cancer</source><comment></comment></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsugane</surname><given-names>S</given-names></name><name><surname>de Souza</surname><given-names>JM</given-names></name><name><surname>Costa</surname><given-names>ML</given-names><suffix>Jr</suffix></name><name><surname>Mirra</surname><given-names>AP</given-names></name><name><surname>Gotlieb</surname><given-names>SL</given-names></name><name><surname>Laurenti</surname><given-names>R</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name></person-group><article-title>Cancer incidence rates among Japanese immigrants in the city of S&#x000e3;o Paulo, Brazil, 1969&#x02013;78</article-title><source>Cancer Causes Control</source><year>1990</year><volume>1</volume><fpage>189</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">2102290</pub-id><pub-id pub-id-type="doi">10.1007/BF00053172</pub-id></citation></ref><ref id="B30"><citation citation-type="other"><person-group person-group-type="author"><collab>U.S. Department of Agriculture, Agricultural Research Service</collab></person-group><article-title>USDA National Nutrient Database for Standard Reference, Release 18</article-title><source>Nutrient Data Laboratory Home Page</source><year>2006</year><ext-link ext-link-type="uri" xlink:href="http://www.ars.usda.gov/ba/bhnrc/ndl"/></citation></ref><ref id="B31"><citation citation-type="book"><person-group person-group-type="author"><collab>Council for Science and Technology; Ministry of Education C, Sports, Science and Technology; the Government of Japan</collab></person-group><source>Standard Tables of Food Composition in Japan, the fifth revised and enlarged edition</source><year>2005</year><publisher-name>Tokyo: Printing Bureau, Ministry of Finance</publisher-name></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willett</surname><given-names>W</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name></person-group><article-title>Total energy intake: implications for epidemiologic analyses</article-title><source>Am J Epidemiol</source><year>1986</year><volume>124</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">3521261</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stolzenberg-Solomon</surname><given-names>RZ</given-names></name><name><surname>Chang</surname><given-names>SC</given-names></name><name><surname>Leitzmann</surname><given-names>MF</given-names></name><name><surname>Johnson</surname><given-names>KA</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Buys</surname><given-names>SS</given-names></name><name><surname>Hoover</surname><given-names>RN</given-names></name><name><surname>Ziegler</surname><given-names>RG</given-names></name></person-group><article-title>Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>83</volume><fpage>895</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">16600944</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>CM</given-names></name></person-group><article-title>Folate and cancer prevention: a closer look at a complex picture</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>86</volume><fpage>271</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17684194</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Helzlsouer</surname><given-names>KJ</given-names></name><name><surname>Comstock</surname><given-names>GW</given-names></name><name><surname>Hoffman</surname><given-names>SC</given-names></name><name><surname>Nadeau</surname><given-names>MR</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name></person-group><article-title>A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>1999</year><volume>8</volume><fpage>209</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">10090298</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>K</given-names></name><name><surname>Davidson</surname><given-names>NE</given-names></name><name><surname>Hunter</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Payne-Wilks</surname><given-names>K</given-names></name><name><surname>Roland</surname><given-names>CL</given-names></name><name><surname>Phillips</surname><given-names>D</given-names></name><name><surname>Bentley</surname><given-names>C</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>SM</given-names></name></person-group><article-title>Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes</article-title><source>Cancer Causes Control</source><year>2003</year><volume>14</volume><fpage>827</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">14682440</pub-id><pub-id pub-id-type="doi">10.1023/B:CACO.0000003823.97506.be</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>L</given-names></name><name><surname>Little</surname><given-names>J</given-names></name><name><surname>Schofield</surname><given-names>AC</given-names></name><name><surname>Pavlidou</surname><given-names>E</given-names></name><name><surname>Cotton</surname><given-names>SC</given-names></name><name><surname>Miedzybrodzka</surname><given-names>Z</given-names></name><name><surname>Baird</surname><given-names>JO</given-names></name><name><surname>Haites</surname><given-names>NE</given-names></name><name><surname>Heys</surname><given-names>SD</given-names></name><name><surname>Grubb</surname><given-names>DA</given-names></name></person-group><article-title>Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR)</article-title><source>Cancer Lett</source><year>2002</year><volume>181</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12430180</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3835(02)00030-7</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baglietto</surname><given-names>L</given-names></name><name><surname>English</surname><given-names>DR</given-names></name><name><surname>Gertig</surname><given-names>DM</given-names></name><name><surname>Hopper</surname><given-names>JL</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name></person-group><article-title>Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study</article-title><source>BMJ</source><year>2005</year><volume>331</volume><fpage>807</fpage><pub-id pub-id-type="pmid">16087654</pub-id><pub-id pub-id-type="doi">10.1136/bmj.38551.446470.06</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>IM</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Selhub</surname><given-names>J</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Zhang</surname><given-names>SM</given-names></name></person-group><article-title>Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><fpage>734</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">18326613</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>E</given-names></name><name><surname>Holmes</surname><given-names>M</given-names></name><name><surname>Hankinson</surname><given-names>SE</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2007</year><volume>16</volume><fpage>2787</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">18086790</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-0683</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YI</given-names></name></person-group><article-title>Does a high folate intake increase the risk of breast cancer?</article-title><source>Nutr Rev</source><year>2006</year><volume>64</volume><fpage>468</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17063929</pub-id><pub-id pub-id-type="doi">10.1111/j.1753-4887.2006.tb00178.x</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Gammon</surname><given-names>MD</given-names></name><name><surname>Wetmur</surname><given-names>JG</given-names></name><name><surname>Bradshaw</surname><given-names>PT</given-names></name><name><surname>Teitelbaum</surname><given-names>SL</given-names></name><name><surname>Neugut</surname><given-names>AI</given-names></name><name><surname>Santella</surname><given-names>RM</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2008</year><volume>17</volume><fpage>2109</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">18708404</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-2900</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SA</given-names></name><name><surname>Kang</surname><given-names>D</given-names></name><name><surname>Nishio</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Yoo</surname><given-names>KY</given-names></name><name><surname>Ahn</surname><given-names>SH</given-names></name><name><surname>Choe</surname><given-names>KJ</given-names></name><name><surname>Hirvonen</surname><given-names>A</given-names></name><name><surname>Noh</surname><given-names>DY</given-names></name></person-group><article-title>Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women</article-title><source>Exp Mol Med</source><year>2004</year><volume>36</volume><fpage>116</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15150439</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Sturgis</surname><given-names>EM</given-names></name><name><surname>Spitz</surname><given-names>MR</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name></person-group><article-title>Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2005</year><volume>14</volume><fpage>1188</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15894670</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-04-0501</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silaste</surname><given-names>ML</given-names></name><name><surname>Rantala</surname><given-names>M</given-names></name><name><surname>S&#x000e4;mpi</surname><given-names>M</given-names></name><name><surname>Alfthan</surname><given-names>G</given-names></name><name><surname>Aro</surname><given-names>A</given-names></name><name><surname>Kes&#x000e4;niemi</surname><given-names>YA</given-names></name></person-group><article-title>Polymorphisms of Key Enzymes in Homocysteine Metabolism Affect Diet Responsiveness of Plasma Homocysteine in Healthy Women</article-title><source>J Nutr</source><year>2001</year><volume>131</volume><fpage>2643</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11584084</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CP</given-names></name><name><surname>Wu</surname><given-names>MH</given-names></name><name><surname>Chou</surname><given-names>YC</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>You</surname><given-names>SL</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Sun</surname><given-names>CA</given-names></name></person-group><article-title>Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: a nested case-control study in Taiwan</article-title><source>Anticancer Res</source><year>2007</year><volume>27</volume><fpage>1727</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17595805</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Marchand</surname><given-names>L</given-names></name><name><surname>Donlon</surname><given-names>T</given-names></name><name><surname>Hankin</surname><given-names>JH</given-names></name><name><surname>Kolonel</surname><given-names>LN</given-names></name><name><surname>Wilkens</surname><given-names>LR</given-names></name><name><surname>Seifried</surname><given-names>A</given-names></name></person-group><article-title>B-vitamin intake, metabolic genes, and colorectal cancer risk (United States)</article-title><source>Cancer Causes Control</source><year>2002</year><volume>13</volume><fpage>239</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">12020105</pub-id><pub-id pub-id-type="doi">10.1023/A:1015057614870</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>J</given-names></name><name><surname>Otani</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Iwasaki</surname><given-names>M</given-names></name><name><surname>Sasazuki</surname><given-names>S</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name><collab>Japan Public Health Center-based Prospective Study Group</collab></person-group><article-title>Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men</article-title><source>J Nutr</source><year>2007</year><volume>137</volume><fpage>1808</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">17585035</pub-id></citation></ref></ref-list></back></article> 